Significant improvement of response rate and survival with cisplatin, epirubicin, 5-fluorouracil and gemcitabine (PEF-G regimen) in metastatic pancreatic cancer
- 30 September 1999
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 35, S149-149
- https://doi.org/10.1016/s0959-8049(99)80975-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: